PIC
EW icon

PCJ Investment Counsel’s Edwards Lifesciences EW Stock Holding History

PCJ Investment Counsel’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,000
Closed -$2.07M – 83
2021
Q2 		$2.07M Buy
+20,000
New +$1.89M 0.78% 49

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PCJ Investment Counsel's EW Position: Q3 2021 in Review

PCJ Investment Counsel sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 20,000 shares — an estimated $2.07M sold.

PCJ Investment Counsel first reported a position in EW in Q2 2021 and held it in 1 quarter. The position peaked at $2.07M in Q2 2021. 1,227 funds tracked by Wall St. Rank hold EW as of Q3 2021.

  • PCJ Investment Counsel reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
  • PCJ Investment Counsel sold 20,000 Edwards Lifesciences shares in Q3 2021, an estimated $2.07M.
  • PCJ Investment Counsel first reported a position in Edwards Lifesciences in Q2 2021 and held it in 1 quarter.
  • PCJ Investment Counsel's Edwards Lifesciences position peaked at $2.07M in Q2 2021.
  • 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on PCJ Investment Counsel's 13F filing for Q3 2021, filed 10 Nov 2021.